Peer-reviewedCC BY-NC-NDEClinicalMedicine
Adjuvant radiotherapy in FIGO stage III dMMR endometrial cancer: evidence and perspectives in the molecular era
Related
- Cancer-associated fibroblasts and immune evasion in endometrial cancer: current evidence and therapeutic perspectives
- The Molecular, Genetic, Pathological Basis and Clinical Perspectives of Endometrial Cancer: A Narrative Review
- Malignant Proliferating Trichilemmal Tumor of the Scalp Treated With Excision and Adjuvant Radiotherapy
- Adjuvant immunotherapy after curative-intent treatment for hepatocellular carcinoma: evidence, limitations, and a research framework for molecular residual disease-guided intervention-a narrative review.
- Palatal Island Flap With Adjuvant Radiotherapy for Hard Palate Adenoid Cystic Carcinoma: 2-year Outcomes
BibTeX
@article{macchia2026adjuvant,
title = {{Adjuvant radiotherapy in FIGO stage III dMMR endometrial cancer: evidence and perspectives in the molecular era}},
author = {Gabriella Macchia and AnnaMaria Merlotti and Francesca De Felice and Donatella Russo and Claudia Marchetti and Domenica Lorusso},
journal = {EClinicalMedicine},
year = {2026},
month = oct,
doi = {10.1016/j.eclinm.2026.104257},
url = {https://europepmc.org/article/PMC/PMC13676119},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Adjuvant radiotherapy in FIGO stage III dMMR endometrial cancer: evidence and perspectives in the molecular era
AU - Gabriella Macchia
AU - AnnaMaria Merlotti
AU - Francesca De Felice
AU - Donatella Russo
AU - Claudia Marchetti
AU - Domenica Lorusso
PY - 2026
DA - 2026/10/07
JO - EClinicalMedicine
DO - 10.1016/j.eclinm.2026.104257
UR - https://europepmc.org/article/PMC/PMC13676119
SN - 2589-5370
ER -